194 related articles for article (PubMed ID: 15277371)
1. PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet.
van den Hoek AM; Heijboer AC; Corssmit EP; Voshol PJ; Romijn JA; Havekes LM; Pijl H
Diabetes; 2004 Aug; 53(8):1949-52. PubMed ID: 15277371
[TBL] [Abstract][Full Text] [Related]
2. Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice.
van den Hoek AM; Heijboer AC; Voshol PJ; Havekes LM; Romijn JA; Corssmit EP; Pijl H
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E238-45. PubMed ID: 16940471
[TBL] [Abstract][Full Text] [Related]
3. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
Oakes ND; Thalén PG; Jacinto SM; Ljung B
Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421
[TBL] [Abstract][Full Text] [Related]
4. Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin.
van den Hoek AM; Voshol PJ; Karnekamp BN; Buijs RM; Romijn JA; Havekes LM; Pijl H
Diabetes; 2004 Oct; 53(10):2529-34. PubMed ID: 15448080
[TBL] [Abstract][Full Text] [Related]
5. CL-316,243, a beta3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats.
de Souza CJ; Hirshman MF; Horton ES
Diabetes; 1997 Aug; 46(8):1257-63. PubMed ID: 9231648
[TBL] [Abstract][Full Text] [Related]
6. Hexokinase II overexpression improves exercise-stimulated but not insulin-stimulated muscle glucose uptake in high-fat-fed C57BL/6J mice.
Fueger PT; Bracy DP; Malabanan CM; Pencek RR; Granner DK; Wasserman DH
Diabetes; 2004 Feb; 53(2):306-14. PubMed ID: 14747279
[TBL] [Abstract][Full Text] [Related]
7. GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet.
Parlevliet ET; de Leeuw van Weenen JE; Romijn JA; Pijl H
Am J Physiol Endocrinol Metab; 2010 Aug; 299(2):E318-24. PubMed ID: 20530733
[TBL] [Abstract][Full Text] [Related]
8. CNTO736, a novel glucagon-like peptide-1 receptor agonist, ameliorates insulin resistance and inhibits very low-density lipoprotein production in high-fat-fed mice.
Parlevliet ET; Schröder-van der Elst JP; Corssmit EP; Picha K; O'Neil K; Stojanovic-Susulic V; Ort T; Havekes LM; Romijn JA; Pijl H
J Pharmacol Exp Ther; 2009 Jan; 328(1):240-8. PubMed ID: 18849357
[TBL] [Abstract][Full Text] [Related]
9. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.
Oakes ND; Kennedy CJ; Jenkins AB; Laybutt DR; Chisholm DJ; Kraegen EW
Diabetes; 1994 Oct; 43(10):1203-10. PubMed ID: 7926289
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the metabolic effects of GIP receptor antagonism and PYY(3-36) receptor activation in high fat fed mice.
Irwin N; Hunter K; Flatt PR
Peptides; 2007 Nov; 28(11):2192-8. PubMed ID: 17884253
[TBL] [Abstract][Full Text] [Related]
11. Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects.
Sloth B; Holst JJ; Flint A; Gregersen NT; Astrup A
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1062-8. PubMed ID: 17148749
[TBL] [Abstract][Full Text] [Related]
12. Tofogliflozin Improves Insulin Resistance in Skeletal Muscle and Accelerates Lipolysis in Adipose Tissue in Male Mice.
Obata A; Kubota N; Kubota T; Iwamoto M; Sato H; Sakurai Y; Takamoto I; Katsuyama H; Suzuki Y; Fukazawa M; Ikeda S; Iwayama K; Tokuyama K; Ueki K; Kadowaki T
Endocrinology; 2016 Mar; 157(3):1029-42. PubMed ID: 26713783
[TBL] [Abstract][Full Text] [Related]
13. High-fat- and lipid-induced insulin resistance in rats: the comparison of glucose metabolism, plasma resistin and adiponectin levels.
Li L; Yang G; Li Q; Tang Y; Li K
Ann Nutr Metab; 2006; 50(6):499-505. PubMed ID: 17191023
[TBL] [Abstract][Full Text] [Related]
14. Chronic free fatty acid infusion in rats results in insulin resistance but no alteration in insulin-responsive glucose transporter levels in skeletal muscle.
Magnan C; Gilbert M; Kahn BB
Lipids; 1996 Nov; 31(11):1141-9. PubMed ID: 8934446
[TBL] [Abstract][Full Text] [Related]
15. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
[TBL] [Abstract][Full Text] [Related]
16. Acute peripheral tissue effects of ghrelin on interstitial levels of glucose, glycerol, and lactate: a microdialysis study in healthy human subjects.
Vestergaard ET; Møller N; Jørgensen JO
Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1273-80. PubMed ID: 23592479
[TBL] [Abstract][Full Text] [Related]
17. NPY modulates PYY function in the regulation of energy balance and glucose homeostasis.
Zhang L; Nguyen AD; Lee IC; Yulyaningsih E; Riepler SJ; Stehrer B; Enriquez RF; Lin S; Shi YC; Baldock PA; Sainsbury A; Herzog H
Diabetes Obes Metab; 2012 Aug; 14(8):727-36. PubMed ID: 22369253
[TBL] [Abstract][Full Text] [Related]
18. Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats.
Kim JK; Wi JK; Youn JH
Diabetes; 1996 Apr; 45(4):446-53. PubMed ID: 8603766
[TBL] [Abstract][Full Text] [Related]
19. PYY3-36 injection in mice produces an acute anorexigenic effect followed by a delayed orexigenic effect not observed with other anorexigenic gut hormones.
Parkinson JR; Dhillo WS; Small CJ; Chaudhri OB; Bewick GA; Pritchard I; Moore S; Ghatei MA; Bloom SR
Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E698-708. PubMed ID: 18285527
[TBL] [Abstract][Full Text] [Related]
20. Oxyntomodulin ameliorates glucose intolerance in mice fed a high-fat diet.
Parlevliet ET; Heijboer AC; Schröder-van der Elst JP; Havekes LM; Romijn JA; Pijl H; Corssmit EP
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E142-7. PubMed ID: 17971509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
